glp 1 a Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists A Comprehensive Review of the

Description

Its predominant action is on the postprandial glucose levels, with extraglycemic effects on fat metabolism and endovascular function

The overaccumulation of triacylglycerol and cholesterol in the hepatocytes and the overproduction of reactive oxygen species (ROS) both lead to local inflammatory responses

Can diet alone restore metabolic health after GLP-1 use

Smaller portions mean less of everything, including the nutrients that have nothing to do with weight and everything to do with how you feel day to day

These preclinical findings support clinical trial results showing that tirzepatide, a dual GIPR/GLP-1R agonist, exhibits greater anti-obesity effects than GLP-1 receptor agonists alone